Julien's Primer of Drug Action - Claire D. Advokat, Robert Julien, Joseph Comaty

Julien's Primer of Drug Action

Buch | Softcover
672 Seiten
2018 | 14th ed. 2019
Worth Publishers Inc.,U.S. (Verlag)
978-1-319-24894-9 (ISBN)
80,88 inkl. MwSt
In its 40th anniversary edition, A Primer of Drug Action continues to evolve side by side with the field it covers, drawing on the expertise of its authors in medicine, basic science, and clinical science to offer the most current and comprehensive guide to psychopharmacology available.
Julien’s Primer of Drug Action continues to evolve side by side with the field it covers providing a thoroughly up to date look at psychotherapeutic and recreational drugs, including the latest research and the newest formulations.  

The thoroughly updated 14th edition features:





New coverage of opioids of abuse, and  drugs used to treat of opioid dependence and opioid overdose

New research on the use of marijuana to treat Alzheimers, PTSD,  and Epilepsy

New coverage of pharmacological, physiological, and psychoactive effects  of synthetic marijuana including its toxicity

New research on Cannabidiol (CBD) and its therapeutic uses

New research of the efficacy of  antipsychotics to treat  dementia, Parkinson’s, bipolar, OCD, and PTSD

The use of genetic testing to predict effectiveness of antidepressant treatment

New research on the use of ketamine for the treatment of depression

Claire Advokat received her Ph.D. in physiological psychology from Rutgers University. Her research area is psychopharmacology, specifically drugs used in the treatment of psychiatric and behavioral disorders. She has published over 80 articles, and received funding for her studies from the National Institute of Drug Abuse (NIDA), the Spencer Foundation, the Board of Regents of Louisiana, the State of Louisiana, and the pharmaceutical firm NPS. She received a university teaching award in 2005, served as an ad hoc reviewer for 20 journals, and serves on the editorial board of The Journal of Attention Disorders.

Part 1 Biological Basis of Drug Action1. The Neuron, Synaptic Transmission, and Neurotransmitters.- 2. Pharmacokinetics: How the Body Handles Drugs.-  3. Pharmacodynamics: How Drugs Act.- Part 2 Pharmacology of Drugs of Abuse.- 4. Neurobiology of Addiction.- 5. Ethyl Alcohol and the Inhalants of Abuse.- 6. Stimulants Part .- 1 Caffeine and Nicotine7. Stimulants Part.-  2 Cocaine, Amphetamine, NonAmphetamine Stimulants.- 8. Hallucinogens.-  9. Cannabinoids.- 10. Opioids .- Part 3 Drugs Used to Treat Psychological Disorders.- 11. Antipsychotic Drugs: Major Tranquilizers to Thymic Stabilizers.- 12. Antidepressant Drugs.- 13. Sedative-Hypnotic and Anxiolytic Medications.- 14. Drugs Used to Treat Bipolar Disorder.- Part 4 Special Populations and Integration.- 15. Child and Adolescent Psychopharmacology.- 16. Geriatric Psychopharmacology.- 17. Integration.- Chapter 17 Appendix: Quick .- Reference to Psychotropic Medications.

Erscheinungsdatum
Zusatzinfo 672 p.
Sprache englisch
Maße 155 x 235 mm
Themenwelt Geisteswissenschaften Psychologie Persönlichkeitsstörungen
Medizin / Pharmazie Medizinische Fachgebiete Psychiatrie / Psychotherapie
Schlagworte Antidepressiva • Bipolar Disorder • Cannabinoid • Cocaine • Drug • Drug research • drugs of abuse • DSM-5 • Kinetics • Nicotin • Pharmacodynamics • Pharmacokinetics • pharmacology • Psychopharmacology • Research
ISBN-10 1-319-24894-2 / 1319248942
ISBN-13 978-1-319-24894-9 / 9781319248949
Zustand Neuware
Haben Sie eine Frage zum Produkt?
Mehr entdecken
aus dem Bereich

von Michael Soyka; Anil Batra; Andreas Heinz; Franz Moggi …

Buch | Hardcover (2022)
Urban & Fischer in Elsevier (Verlag)
82,00